Serum calprotectin as a novel biomarker for severity of COVID-19 disease-Reference-Cited by-同舟云学术

Serum calprotectin as a novel biomarker for severity of COVID-19 disease

Published:2021-02-27 Issue:1 Volume:191 Page:59-64
ISSN:0021-1265
Container-title:Irish Journal of Medical Science (1971 -)
language:en
Short-container-title:Ir J Med Sci

Author:

Kaya Tezcan^ORCID,Yaylacı Selçuk^ORCID,Nalbant Ahmet^ORCID,Yıldırım İlhan,Kocayiğit Havva^ORCID,Çokluk Erdem,Şekeroğlu Mehmet Ramazan^ORCID,Köroğlu Mehmet,Güçlü Ertuğrul^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11845-021-02565-8.pdf

Reference20 articles.

1. Huang R, Zhuid L, Xue L et al (2020) Clinical findings of patients with coronavirus disease 2019 in Jiangsu Province, China: a retrospective, multi-center study. PLoS Negl Trop Dis 14:1–14. https://doi.org/10.1371/journal.pntd.0008280

2. Kouhsari E, Azizian K, Sholeh M et al (2020) Clinical, epidemiological, laboratory, and radiological characteristics of novel Coronavirus (2019-nCoV) in retrospective studies: a systemic review and meta-analysis. Indian J Med Microbiol. https://doi.org/10.1016/j.ijmmb.2020.10.004

3. Pourbagheri-Sigaroodi A, Bashash D, Fateh F et al (2020) Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta 510:475–482. https://doi.org/10.1016/j.cca.2020.08.019

4. Ponti G, Maccaferri M, Ruini C et al (2020) Biomarkers associated with COVID-19 disease progression Crit Rev Clin Lab Sci 1-11. https://doi.org/10.1080/10408363.2020.1770685

5. Ghahramani S, Tabrizi R, Lankarani KB et al (2020) Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res 25:1–10. https://doi.org/10.1186/s40001-020-00432-3

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increasing plasma calprotectin (S100A8/A9) is associated with 12-month mortality and unfavourable functional outcome in critically ill COVID-19 patients;Journal of Intensive Care;2024-07-09

2. Role of Inflammatory Markers in Severity, ICU Admission, and Mortality in COVID-19: A Systematic Review and Meta-analysis of 79,934 Patients;Barw Medical Journal;2024-06-25

3. Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID‐19;Immunity, Inflammation and Disease;2024-03

4. Determination of Serum Calprotectin, Heparin-Binding Protein, and Some Inflammatory Factors in Patients with COVID-19;Archives of Clinical Infectious Diseases;2023-11-25

5. Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study;European Journal of Internal Medicine;2023-11